Eli Lilly’s weight loss drug, tirzepatide, showed substantial potential in a large Phase 3 study, the results of which were reported on April 28th. If tirzepatide gets approved, it could become a blockbuster. But, this isn’t a sure thing. It will have …
A new Covid-19 monoclonal antibody, 35B5, has the potential to neutralize all current and future SARS-CoV-2 variant strains.
The Biden Administration’s Test-to-treat program has the potential to transform the pandemic, especially for those at high risk of severe disease.
The CDC’s new Center for Forecasting and Outbreak Analytics aims to act in a similar way to the weather forecast to guide decisions about broad public health needs. But the system will only be as effective as the data it receives.
Hyperinflammation is responsible for much of the damage in acute Covid-19. Generalized inflammation is a major contributor to long Covid. New research suggests that the SARS-CoV-2 spike protein can induce syncytia formation in the lungs, triggering a s…
A recent study found that N protein mutations common in many variants of concern play a major role in transmissibility and virulence.
Activating STING-mediated innate immunity requires second messenger molecules to bind onto the protein. In this next part of our series, we will delve deeper into the discovery that uncovered a new group of second messengers that may help to control in…
A new study from the U.K. has described drug-resistant lung infections in vulnerable people, raising concern that treatment options may be increasingly limited.
Inflammation is one of the most serious consequences of infection and is a hallmark of severe SARS-CoV-2. Recent studies show that SARS-CoV-2 induces the innate immune system’s inflammatory response by mimicking one of our body’s most potent inflammato…
A new study from the UK has linked obsession with failure and hunt for perfection to burnout in athletes.
